Announcements

ASX Announcements for Rhythm Biosciences

ASX Announcements for Rhythm Biosciences can be accessed through the links provided here.

Any person may also request a copy of any of the announcements referred to below free of charge by contacting Rhythm Biosciences.

25-05-02 Notification regarding unquoted securities - RHY
25-05-02 Notification regarding unquoted securities - RHY
25-05-01 Proposed issue of securities - RHY
25-05-01 Proposed issue of securities - RHY
25-04-24 Quarterly Activities Report and Appendix 4C 31 March 2025
25-04-24 Quarterly Activities Report and Appendix 4C 31 March 2025
25-04-14 RHY ISO13485 Recert Market Update
25-04-14 RHY ISO13485 Recert Market Update
25-04-11 Application for quotation of securities - RHY
25-04-11 Application for quotation of securities - RHY
25-04-08 Change in substantial holding
25-04-08 Change in substantial holding
25-03-31 EGM - Investor Presentation
25-03-31 EGM - Investor Presentation
25-03-31 RHY - Results of Meeting
25-03-31 RHY - Results of Meeting
25-03-19 RHY Genetype Commercial Sales
25-03-19 RHY Genetype Commercial Sales
25-03-18 Appointment of Chief Financial Officer
25-03-18 Appointment of Chief Financial Officer
25-03-18 Notification regarding unquoted securities - RHY
25-03-18 Notification regarding unquoted securities - RHY
25-03-17 Notification of cessation of securities - RHY
25-03-17 Notification of cessation of securities - RHY
25-03-05 RHY Investor Webinar
25-03-05 RHY Investor Webinar
25-02-27 RHY - EGM Notice of Meeting and Proxy Form
25-02-27 RHY - EGM Notice of Meeting and Proxy Form
25-02-27 Investor Webinar
25-02-27 Investor Webinar
25-02-21 Half-Year Financial Report and Appendix 4D
25-02-21 Half-Year Financial Report and Appendix 4D
25-02-12 Becoming a substantial holder
25-02-12 Becoming a substantial holder
25-02-04 Genetype Commercial Integration Completion
25-02-04 Genetype Commercial Integration Completion
25-01-23 Quarterly Activities Report and Appendix 4C - Dec24
25-01-23 Quarterly Activities Report and Appendix 4C - Dec24
25-01-14 About the Genetype Acquisition
25-01-14 About the Genetype Acquisition
2024 Announcements
24-12-24 - Completion of Genetype Risk Assessment Portfolio Acquisition
24-12-24 - Completion of Genetype Risk Assessment Portfolio Acquisition
23-Dec-24 - RHY Genetype acquisition
23-Dec-24 - RHY Genetype acquisition
20-Dec-24 Request for Trading Halt
20-Dec-24 Request for Trading Halt
18-Dec-2024 - Market Update - All End of CY24 Milestones Attained
18-Dec-2024 - Market Update - All End of CY24 Milestones Attained
2-Dec-2024 - Change in substantial holding - Otto Buttula
2-Dec-2024 - Change in substantial holding - Otto Buttula
2-Dec-2024 - Initial Director's Interest Notice
2-Dec-2024 - Initial Director's Interest Notice
2-Dec-2024 - Board Changes Effected
2-Dec-2024 - Board Changes Effected
29-Nov-2024 - Application for quotation of securities - RHY
29-Nov-2024 - Application for quotation of securities - RHY
21-Nov-2024 - Final Director's Interest Notice - Lou Panaccio
21-Nov-2024 - Final Director's Interest Notice - Lou Panaccio
21-Nov-2024 - Final Director's Interest Notice - Trevor Lockett
21-Nov-2024 - Final Director's Interest Notice - Trevor Lockett
20-Nov-2024 - 2024 AGM Results
20-Nov-2024 - 2024 AGM Results
20-Nov-2024 - 2024 AGM Chairman's Address & Post AGM Presentation
20-Nov-2024 - 2024 AGM Chairman's Address & Post AGM Presentation
20-Nov-2024 - Board Composition Update - NED Resignations
20-Nov-2024 - Board Composition Update - NED Resignations
19-Nov-2024 - Proposed issue of securities
19-Nov-2024 - Proposed issue of securities
19-Nov-2024 - Placement Issue Investor Presentation
19-Nov-2024 - Placement Issue Investor Presentation
19-Nov-2024 - Placement Prospectus
19-Nov-2024 - Placement Prospectus
19-Nov-2024 - Strong Demand in Share Placement to Raise $3.5 million
19-Nov-2024 - Strong Demand in Share Placement to Raise $3.5 million
18-Nov-2024 - Notification regarding unquoted securities RHY
18-Nov-2024 - Notification regarding unquoted securities RHY
18-Nov-2024 - Notification regarding unquoted securities
18-Nov-2024 - Notification regarding unquoted securities
18-Nov-2024 - Awarding of Employee Options and Loan Shares to Management
18-Nov-2024 - Awarding of Employee Options and Loan Shares to Management
15-Nov-2024 - Trading Halt
15-Nov-2024 - Trading Halt
11-Nov-2024 - New, Independent, Non-Executive Director to be Appointed
11-Nov-2024 - New, Independent, Non-Executive Director to be Appointed
7-Nov-2024 - Receipt of Research & Development Tax Incentive
7-Nov-2024 - Receipt of Research & Development Tax Incentive
24-Oct-2024 - Market Presentation
24-Oct-2024 - Market Presentation
24-Oct-2024 - Appendix 4C and Market Update
24-Oct-2024 - Appendix 4C and Market Update
18-Oct-2024 - RHY 2024 AGM Nominations & Proxy Form
18-Oct-2024 - RHY 2024 AGM Nominations & Proxy Form
7-Oct-2024 - 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
7-Oct-2024 - 2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
30-Sep-2024 - Initial Director's Interest Notice - David Atkins
30-Sep-2024 - Initial Director's Interest Notice - David Atkins
30-Sep-2024 - Board Renewal - Composition Update
30-Sep-2024 - Board Renewal - Composition Update
26-Sep-2024 - Corporate Governance Statement
26-Sep-2024 - Corporate Governance Statement
26-Sep-2024 - RHY FY2024 Annual Report
26-Sep-2024 - RHY FY2024 Annual Report
24-Sep-2024 - Platform Expansion - Gastric Cancer Diagnostic Test Update
24-Sep-2024 - Platform Expansion - Gastric Cancer Diagnostic Test Update
10-Sep-2024 -AGM date and closing date for director nominations
10-Sep-2024 -AGM date and closing date for director nominations
30-Aug-2024 - Appendix 4G
30-Aug-2024 - Appendix 4G
30-Aug-2024 - RHY Financial Report FY2024
30-Aug-2024 - RHY Financial Report FY2024
30-Aug-2024 - Appendix 4E
30-Aug-2024 - Appendix 4E
28-Aug-2024 - Product and Market Update - Phase 2 Milestone
28-Aug-2024 - Product and Market Update - Phase 2 Milestone
19-Aug-2024 - Notification of cessation of securities
19-Aug-2024 - Notification of cessation of securities
14-Aug-2024 - FY2024 R&D Tax Incentive Loan Funding
14-Aug-2024 - FY2024 R&D Tax Incentive Loan Funding
7-Aug-2024 - Change of Director's Interest Notice - Otto Buttula
7-Aug-2024 - Change of Director's Interest Notice - Otto Buttula
7-Aug-2024 - Change of Director's Interest Notice - Lou Panaccio
7-Aug-2024 - Change of Director's Interest Notice - Lou Panaccio
7-Aug-2024 - Change of Director's Interest Notice - Trevor Lockett
7-Aug-2024 - Change of Director's Interest Notice - Trevor Lockett
1-Aug-2024 - Notification of cessation of securities
1-Aug-2024 - Notification of cessation of securities
29-July-2024 - Quarterly Activities Report and Appendix 4C
29-July-2024 - Quarterly Activities Report and Appendix 4C
12-July-2024 - Bioshares Biotech Summit Presentation
12-July-2024 - Bioshares Biotech Summit Presentation
17-June-2024 - Close of Shortfall Offer Pursuant to the Rights Issue
17-June-2024 - Close of Shortfall Offer Pursuant to the Rights Issue
17-June-2024 - Change of Director's Interest Notice - Otto Buttula
17-June-2024 - Change of Director's Interest Notice - Otto Buttula
04-June-2024 - Change of Director's Interest Notice - Otto Buttula
04-June-2024 - Change of Director's Interest Notice - Otto Buttula
28-May-2024 - Change of Director's Interest Notice - Otto Buttula
28-May-2024 - Change of Director's Interest Notice - Otto Buttula
27-May-2024 - Cancel - Notification regarding unquoted securities
27-May-2024 - Cancel - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
27-May-2024 - Notification regarding unquoted securities
22-May-2024 - Otto Buttula to Revert Back to Non-Executive Chair
22-May-2024 - Otto Buttula to Revert Back to Non-Executive Chair
7-May-2024 - Application for quotation of securities
7-May-2024 - Application for quotation of securities
30-April-2024 - Quarterly Activities Report and Appendix 4C
30-April-2024 - Quarterly Activities Report and Appendix 4C
24-April-2024 - Dr David Atkins Appointed Chief Executive Officer of Rhythm Biosciences
24-April-2024 - Dr David Atkins Appointed Chief Executive Officer of Rhythm Biosciences
23-April-2024 - Rhythm Maintains ISO Certification
23-April-2024 - Rhythm Maintains ISO Certification
2-April-2024 - Change in substantial holding - Otto Buttula
2-April-2024 - Change in substantial holding - Otto Buttula
27-March-2024 - Change of Director's Interest Notice - Trevor Lockett
27-March-2024 - Change of Director's Interest Notice - Trevor Lockett
27-March-2024 - Change of Director's Interest Notice - Lou Panaccio
27-March-2024 - Change of Director's Interest Notice - Lou Panaccio
27-March-2024 - Change of Director's Interest Notice - Otto Buttula
27-March-2024 - Change of Director's Interest Notice - Otto Buttula
25-March-2024 - Notice of ceasing to be a substantial holder
25-March-2024 - Notice of ceasing to be a substantial holder
21-March-2024 - Distribution schedule - RHYO options
21-March-2024 - Distribution schedule - RHYO options
21-March-2024 - Top 20 securityholders - RHYO options
21-March-2024 - Top 20 securityholders - RHYO options
21-March-2024 - Update - Application for quotation of securities
21-March-2024 - Update - Application for quotation of securities
21-March-2024 - Close of Rights Issue
21-March-2024 - Close of Rights Issue
21-March-2024 - Application for quotation of securities
21-March-2024 - Application for quotation of securities
19-March-2024 - Internationally Renowned Clinical Advisory Board Established
19-March-2024 - Internationally Renowned Clinical Advisory Board Established
1-Mar-2024 - S&P DJI Announces March 2024 Quarterly Rebalance
1-Mar-2024 - S&P DJI Announces March 2024 Quarterly Rebalance
29-Feb-2024 - Half Yearly Report and Accounts
29-Feb-2024 - Half Yearly Report and Accounts
28-Feb-2024 - Non-Renounceable Issue - Ineligible Holder Letter
28-Feb-2024 - Non-Renounceable Issue - Ineligible Holder Letter
27-Feb-2024 - Dispatch of Rights Issue Offer Prospectus
27-Feb-2024 - Dispatch of Rights Issue Offer Prospectus
21-Feb-2024 - Rights Issue Investor Presentation
21-Feb-2024 - Rights Issue Investor Presentation
20-Feb-2024 - PAC Partners Appointed Lead Manager
20-Feb-2024 - PAC Partners Appointed Lead Manager
19-Feb-2024 - Rights Issue - Optionholder Letter
19-Feb-2024 - Rights Issue - Optionholder Letter
19-Feb-2024 - Prospectus - 2024 Non-Renounceable Rights Issue
19-Feb-2024 - Prospectus - 2024 Non-Renounceable Rights Issue
16-Feb-2024 - Appendix 3H - Notification of cessation of securities
16-Feb-2024 - Appendix 3H - Notification of cessation of securities
16-Feb-2024 - Market Update
16-Feb-2024 - Market Update
12-Feb-2024 - Results of Extraordinary General Meeting
12-Feb-2024 - Results of Extraordinary General Meeting
12-Feb-2024 - EGM Slides
12-Feb-2024 - EGM Slides
9-Feb-2024 - Proposed issue of securities - RHY
9-Feb-2024 - Proposed issue of securities - RHY
9-Feb-2024 - Rights Issue Offer to Raise Up To $6.6 million
9-Feb-2024 - Rights Issue Offer to Raise Up To $6.6 million
8-Feb-2024 - Update re EGM 12 February 2024
8-Feb-2024 - Update re EGM 12 February 2024
7-Feb-2024 - Trading Halt
7-Feb-2024 - Trading Halt
31-Jan-2024 - Quarterly Activities Report and Appendix 4C
31-Jan-2024 - Quarterly Activities Report and Appendix 4C
04-Jan-2024 - EGM Notice of Meeting
04-Jan-2024 - EGM Notice of Meeting
2023 Announcements
29-Dec-2023 - Appendix 3Z - Final Directors Interest Notice
29-Dec-2023 - Appendix 3Z - Final Directors Interest Notice
29-Dec-2023 - Resignation of Dr Rachel David as Non-executive Director
29-Dec-2023 - Resignation of Dr Rachel David as Non-executive Director
18-Dec-2023 - Strategy and Market Update
18-Dec-2023 - Strategy and Market Update
15-Dec-2023 - Receipt of Notice under Section 249D of the Corporations Act
15-Dec-2023 - Receipt of Notice under Section 249D of the Corporations Act
14-Dec-2023 - Notice of Initial Substantial Holder
14-Dec-2023 - Notice of Initial Substantial Holder
14-Dec-2023 - Appointment of Joint Company Secretary
14-Dec-2023 - Appointment of Joint Company Secretary
24-Nov-2023 - Platform Expansion - Lung Cancer Diagnostic Test Update
24-Nov-2023 - Platform Expansion - Lung Cancer Diagnostic Test Update
15-Nov-2023 - Executive Management Changes
15-Nov-2023 - Executive Management Changes
14-Nov-2023 - Receipt of First Tranche of $1.69m in R&D Tax Incentive
14-Nov-2023 - Receipt of First Tranche of $1.69m in R&D Tax Incentive
31-Oct-2023 - Appendix 4C and Market Update
31-Oct-2023 - Appendix 4C and Market Update
24-Oct-2023 - Appendix 3Y - Change of Directors Interest Notice
24-Oct-2023 - Appendix 3Y - Change of Directors Interest Notice
24-Oct-2023 - Notification regarding unquoted securities
24-Oct-2023 - Notification regarding unquoted securities
18-October-2023 - Response to ASX Query
18-October-2023 - Response to ASX Query
13-October-2023 - Response to ASX Price Query
13-October-2023 - Response to ASX Price Query
13-October-2023 - Pause in Trading
13-October-2023 - Pause in Trading
12-October-2023 - Notice of Initial Substantial Holder
12-October-2023 - Notice of Initial Substantial Holder
10-October-2023 - RHY 2023 AGM Results
10-October-2023 - RHY 2023 AGM Results
10-October-2023 - RHY 2023 AGM Presentation
10-October-2023 - RHY 2023 AGM Presentation
21-September-2023 Breast Cancer Diagnostic Test Update
21-September-2023 Breast Cancer Diagnostic Test Update
18-September-2023 Notification of cessation of +securities
18-September-2023 Notification of cessation of +securities
13-September-2023 RHY Contracts with Nutripath on Automation
13-September-2023 RHY Contracts with Nutripath on Automation
12-September-2023 Application for quotation of +securities
12-September-2023 Application for quotation of +securities
12-September-2023 Cleansing Notice
12-September-2023 Cleansing Notice
01-Sep-2023 AGM Nominations & Proxy Form
01-Sep-2023 AGM Nominations & Proxy Form
Annual Financial Report - 2023
Annual Financial Report - 2023
31-August-2023 Appendix 4G and Corporate Governance Statement
31-August-2023 Appendix 4G and Corporate Governance Statement
31-August-2023 Appendix 4E
31-August-2023 Appendix 4E
08-August-2023 Application for quotation of +securities
08-August-2023 Application for quotation of +securities
08-August-2023 Change of Directors Interest Notice
08-August-2023 Change of Directors Interest Notice
08-August-2023 Cleansing Notice
08-August-2023 Cleansing Notice
01-August-2023 Appendix 3Y - Change of Directors Interest Notice
01-August-2023 Appendix 3Y - Change of Directors Interest Notice
31-July-2023 Appendix 4C and Market Update
31-July-2023 Appendix 4C and Market Update
25-July-2023 Bioshares Summit Presentation
25-July-2023 Bioshares Summit Presentation
04-July-2023 Appointment of Independent, Deputy Chair
04-July-2023 Appointment of Independent, Deputy Chair
03-July-2023 Rhythm Establishes UK Subsidiary for Market Entry
03-July-2023 Rhythm Establishes UK Subsidiary for Market Entry
30-June-2023 Notification of cessation of +securities
30-June-2023 Notification of cessation of +securities
23-June-2023 Revised Securities Trading Policy
23-June-2023 Revised Securities Trading Policy
20-June-2023 Investor Presentation
20-June-2023 Investor Presentation
19-June-2023 Rhythm Continues Platform Expansion Program for Other Cancers
19-June-2023 Rhythm Continues Platform Expansion Program for Other Cancers
06-June-2023 ColoSTAT Poster Presentation at ASCO Annual Meeting
06-June-2023 ColoSTAT Poster Presentation at ASCO Annual Meeting
26-May-2023 Notification of cessation of +securities
26-May-2023 Notification of cessation of +securities
25-May-2023 Response to ASX Query
25-May-2023 Response to ASX Query
24-May-2023 UK Strategic Partnership with LINK Medical Solutions
24-May-2023 UK Strategic Partnership with LINK Medical Solutions
19-May-2023 Application for quotation of +securities
19-May-2023 Application for quotation of +securities
19-May-2023 Cleansing Notice
19-May-2023 Cleansing Notice
18-May-2023 Application for quotation of +securities
18-May-2023 Application for quotation of +securities
18-May-2023 Cleansing Notice
18-May-2023 Cleansing Notice
17-May-2023 UKCA Mark granted for ColoSTAT
17-May-2023 UKCA Mark granted for ColoSTAT
15-May-2023 Form 604 -Change of Interests of Substantial Holder
15-May-2023 Form 604 -Change of Interests of Substantial Holder
15-May-2023 Change of Director's Interest Notice
15-May-2023 Change of Director's Interest Notice
12-May-2023 Notification of cessation of +securities
12-May-2023 Notification of cessation of +securities
27-Apr-2023 Appendix 4C and Market Update
27-Apr-2023 Appendix 4C and Market Update
24-Apr-2023 Appendix 3Z - Final Directors Interest Notice
24-Apr-2023 Appendix 3Z - Final Directors Interest Notice
19-Apr-2023 Executive Management Change
19-Apr-2023 Executive Management Change
06-Apr-2023 ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting
06-Apr-2023 ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting
06-Mar-2023 Reinstatement to Official Quotation
06-Mar-2023 Reinstatement to Official Quotation
06-Mar-2023 Update to TGA Submission
06-Mar-2023 Update to TGA Submission
03-Mar-2023 Suspension from Official Quotation
03-Mar-2023 Suspension from Official Quotation
01-Mar-2023 Trading Halt
01-Mar-2023 Trading Halt
01-Mar-2023 Pause in Trading
01-Mar-2023 Pause in Trading
27-Feb-2023 Change of Share Registry Details
27-Feb-2023 Change of Share Registry Details
23-Feb-2023 Appendix 4D Interim Financial Report
23-Feb-2023 Appendix 4D Interim Financial Report
23-Feb-2023 RHY Institutional Presentation
23-Feb-2023 RHY Institutional Presentation
15-Feb-2023 Rhythm Maintains ISO Certification
15-Feb-2023 Rhythm Maintains ISO Certification
9-Feb-2023 Initial Director's Interest Notice
9-Feb-2023 Initial Director's Interest Notice
31-Jan-2023 Appendix 4C - Quarterly
31-Jan-2023 Appendix 4C - Quarterly
31-Jan-2023 Appointment of New Non-Executive Director
31-Jan-2023 Appointment of New Non-Executive Director
25-Jan-2023 Institutional Presentation
25-Jan-2023 Institutional Presentation
18-Jan-2023 Change of Director's Interest Notice x 2
18-Jan-2023 Change of Director's Interest Notice x 2
10-Jan-2023 Notification regarding unquoted securities - RHY
10-Jan-2023 Notification regarding unquoted securities - RHY
9-Jan-2023 Change of Directors Interest Notice x 4
9-Jan-2023 Change of Directors Interest Notice x 4
4-Jan-2023 Notification of cessation of securities - RHY
4-Jan-2023 Notification of cessation of securities - RHY
2022 Announcements
15-Dec-2022 Institutional Presentation
15-Dec-2022 Institutional Presentation
15-Dec-2022 Market Update
15-Dec-2022 Market Update
15-Dec-2022 RHY Continues Platform Expansion Program for Other Cancers
15-Dec-2022 RHY Continues Platform Expansion Program for Other Cancers
6-Dec-2022 MST Access Diagnostics Forum Presentation (Amended)
6-Dec-2022 MST Access Diagnostics Forum Presentation (Amended)
6-Dec-2022 MST Access Financial Diagnostics Presentation
6-Dec-2022 MST Access Financial Diagnostics Presentation
6-Dec-2022 Final Director's Interest Notice
6-Dec-2022 Final Director's Interest Notice
29-Nov-2022 RHY 2022 AGM Presentation
29-Nov-2022 RHY 2022 AGM Presentation
29-Nov-2022 Results of Meeting
29-Nov-2022 Results of Meeting
29-Nov-2022 Mr. Eduardo Vom Retires as a Non-executive Director
29-Nov-2022 Mr. Eduardo Vom Retires as a Non-executive Director
15-Nov-2022 Application for quotation of securities - RHY
15-Nov-2022 Application for quotation of securities - RHY
10-Nov-2022 Cleansing Notice
10-Nov-2022 Cleansing Notice
10-Nov-2022 Application for quotation of securities - RHY
10-Nov-2022 Application for quotation of securities - RHY
9-Nov-2022 Healthcare Conference Investor Presentation
9-Nov-2022 Healthcare Conference Investor Presentation
3-Nov-2022 ColoSTAT Authorised For Sale In New Zealand
3-Nov-2022 ColoSTAT Authorised For Sale In New Zealand
31-Oct-2022 Notice of Annual General Meeting-Proxy Form
31-Oct-2022 Notice of Annual General Meeting-Proxy Form
31-Oct-2022 Appendix 4C - Quarterly
31-Oct-2022 Appendix 4C - Quarterly
27-Oct-2022 Rhythm Expands Executive Management Team
27-Oct-2022 Rhythm Expands Executive Management Team
26-Oct-2022 Notification of cessation of securities - RHY
26-Oct-2022 Notification of cessation of securities - RHY
24-Oct-2022 Cleansing Notice
24-Oct-2022 Cleansing Notice
24-Oct-2022 Application for quotation of securities - RHY
24-Oct-2022 Application for quotation of securities - RHY
21-Oct-2022 Rhythm Receives $2.7m R&D Tax Incentive
21-Oct-2022 Rhythm Receives $2.7m R&D Tax Incentive
13-Oct-2022 Application for quotation of securities - RHY
13-Oct-2022 Application for quotation of securities - RHY
13-Oct-2022 Cleansing Notice
13-Oct-2022 Cleansing Notice
7-Oct-2022 Application for quotation of securities - RHY
7-Oct-2022 Application for quotation of securities - RHY
7-Oct-2022 Cleansing Notice
7-Oct-2022 Cleansing Notice
5-Oct-2022 Change of Director's Interest Notice x2
5-Oct-2022 Change of Director's Interest Notice x2
4-Oct-2022 Notification of cessation of securities - RHY
4-Oct-2022 Notification of cessation of securities - RHY
30-Sep-2022 Application for quotation of securities - RHY
30-Sep-2022 Application for quotation of securities - RHY
30-Sep-2022 Cleansing Notice
30-Sep-2022 Cleansing Notice
16-Sep-2022 Application for quotation of +securities
16-Sep-2022 Application for quotation of +securities
16-Sep-2022 Cleansing Notice
16-Sep-2022 Cleansing Notice
9-Sep-2022 Change in substantial holding - correction
9-Sep-2022 Change in substantial holding - correction
9-Sep-2022 Cleansing Notice
9-Sep-2022 Cleansing Notice
9-Sep-2022 Application for quotation of +securities
9-Sep-2022 Application for quotation of +securities
9-Sep-2022 Change in substantial holding
9-Sep-2022 Change in substantial holding
9-Sep-2022 Director Share Sale to Institutional Funds Manager
9-Sep-2022 Director Share Sale to Institutional Funds Manager
9-Sep-2022 Change of Director's Interest Notice
9-Sep-2022 Change of Director's Interest Notice
7-Sep-2022 Application for quotation of +securities
7-Sep-2022 Application for quotation of +securities
5-Sep-2022 Change of Director's Interest Notice - Corrected
5-Sep-2022 Change of Director's Interest Notice - Corrected
5-Sep-2022 Change of Director's Interest Notice
5-Sep-2022 Change of Director's Interest Notice
5-Sep-2022 Application for quotation of securities - RHY
5-Sep-2022 Application for quotation of securities - RHY
30-Aug-2022 Application for quotation of securities - RHY
30-Aug-2022 Application for quotation of securities - RHY
30-Aug-2022 Change of Director's Interest Notice
30-Aug-2022 Change of Director's Interest Notice
30-Aug-2022 Cleansing Statement
30-Aug-2022 Cleansing Statement
30-Aug-2022 Change of Director's Interest Notice
30-Aug-2022 Change of Director's Interest Notice
29-Aug-2022 Annual Report
29-Aug-2022 Annual Report
29-Aug-2022 Appendix 4E
29-Aug-2022 Appendix 4E
29-Aug-2022 Appendix 4G and Corporate Governance Statement
29-Aug-2022 Appendix 4G and Corporate Governance Statement
29-Aug-2022 Change of Director's Interest Notice
29-Aug-2022 Change of Director's Interest Notice
26-Aug-2022 Application for quotation of securities - RHY
26-Aug-2022 Application for quotation of securities - RHY
26-Aug-2022 Cleansing Notice
26-Aug-2022 Cleansing Notice
22-Aug-2022 Change of Director's Interest Notice
22-Aug-2022 Change of Director's Interest Notice
19-Aug-2022 Application for quotation of securities - RHY
19-Aug-2022 Application for quotation of securities - RHY
19-Aug-2022 Cleansing Statement
19-Aug-2022 Cleansing Statement
12-Aug-2022 Application for quotation of securities - RHY
12-Aug-2022 Application for quotation of securities - RHY
12-Aug-2022 Cleansing Notice
12-Aug-2022 Cleansing Notice
5-Aug-2022 Application for quotation of securities - RHY
5-Aug-2022 Application for quotation of securities - RHY
5-Aug-2022 Cleansing Notice
5-Aug-2022 Cleansing Notice
1-Aug-2022 Notification to option holders of expiry of unlisted options
1-Aug-2022 Notification to option holders of expiry of unlisted options
1-Aug-2022 Application for quotation of securities - RHY
1-Aug-2022 Application for quotation of securities - RHY
1-Aug-2022 Cleansing Notice
1-Aug-2022 Cleansing Notice
29-Jul-2022 Appendix 4C - Quarterly
29-Jul-2022 Appendix 4C - Quarterly
26-Jul-2022 Application for quotation of securities - RHY
26-Jul-2022 Application for quotation of securities - RHY
26-Jul-2022 Cleansing Notice
26-Jul-2022 Cleansing Notice
19-Jul-2022 RHY Advances Platform Expansion with Other Cancers
19-Jul-2022 RHY Advances Platform Expansion with Other Cancers
20-Jun-2022 Application for quotation of securities - RHY
20-Jun-2022 Application for quotation of securities - RHY
20-Jun-2022 Cleansing Notice
20-Jun-2022 Cleansing Notice
12-May-2022 Completion of Final TGA Submission Step to Approve ColoSTAT
12-May-2022 Completion of Final TGA Submission Step to Approve ColoSTAT
10-May-2022 Application for quotation of securities - RHY
10-May-2022 Application for quotation of securities - RHY
10-May-2022 Cleansing Notice
10-May-2022 Cleansing Notice
4-May-2022 Rhythm Closes Final Clinical Trial Site
4-May-2022 Rhythm Closes Final Clinical Trial Site
28-Apr-2022 Appendix 4C - quarterly
28-Apr-2022 Appendix 4C - quarterly
27-Apr-2022 Application for quotation of securities - RHY
27-Apr-2022 Application for quotation of securities - RHY
27-Apr-2022 Cleansing Notice
27-Apr-2022 Cleansing Notice
12-Apr-2022 Application for quotation of securities - RHY
12-Apr-2022 Application for quotation of securities - RHY
12-Apr-2022 Cleansing Notice
12-Apr-2022 Cleansing Notice
7-Apr-2022 Application for quotation of securities - RHY
7-Apr-2022 Application for quotation of securities - RHY
7-Apr-2022 Cleansing Notice
7-Apr-2022 Cleansing Notice
6-Apr-2022 RHY Presentation at PAC Partners Healthcare Conference
6-Apr-2022 RHY Presentation at PAC Partners Healthcare Conference
5-Apr-2022 Investor Presentation
5-Apr-2022 Investor Presentation
4-Apr-2022 Study 7 Confirms ColoSTAT Meets Primary Endpoint
4-Apr-2022 Study 7 Confirms ColoSTAT Meets Primary Endpoint
18-Mar-2022 Cleansing Notice
18-Mar-2022 Cleansing Notice
18-Mar-2022 Application for quotation of +securities
18-Mar-2022 Application for quotation of +securities
4-Mar-2022 S&P DJI Announces March 2022 Quarterly Rebalance
4-Mar-2022 S&P DJI Announces March 2022 Quarterly Rebalance
2-Mar-2022 Rhythm Biosciences - Investor Webinar Presentation
2-Mar-2022 Rhythm Biosciences - Investor Webinar Presentation
25-Feb-2022 Appendix 4D and Half Yearly Report and Accounts
25-Feb-2022 Appendix 4D and Half Yearly Report and Accounts
25-Feb-2022 Change of Company Address
25-Feb-2022 Change of Company Address
24-Feb-2022 Appointment of New Company Secretary and General Counsel
24-Feb-2022 Appointment of New Company Secretary and General Counsel
24-Feb-2022 Rhythm Investor Webinar
24-Feb-2022 Rhythm Investor Webinar
15-Feb-2022 Rhythm Maintains Ongoing ISO13485 Certification
15-Feb-2022 Rhythm Maintains Ongoing ISO13485 Certification
4-Feb-2022 Application for quotation of securities - RHY
4-Feb-2022 Application for quotation of securities - RHY
4-Feb-2022 Cleansing Notice
4-Feb-2022 Cleansing Notice
1-Feb-2022 Application for quotation of securities - RHY
1-Feb-2022 Application for quotation of securities - RHY
1-Feb-2022 Cleansing Notice
1-Feb-2022 Cleansing Notice
27-Jan-2022 Appendix 4C - quarterly
27-Jan-2022 Appendix 4C - quarterly
13-Jan-2022 Application for quotation of securities - RHY
13-Jan-2022 Application for quotation of securities - RHY
13-Jan-2022 Cleansing Notice
13-Jan-2022 Cleansing Notice
12-Jan-2022 Application for quotation of securities - RHY
12-Jan-2022 Application for quotation of securities - RHY
12-Jan-2022 Cleansing Notice
12-Jan-2022 Cleansing Notice
6-Jan-2022 Placement of $6.5m to Global Institutional Funds Manager
6-Jan-2022 Placement of $6.5m to Global Institutional Funds Manager
6-Jan-2022 Proposed issue of securities - RHY
6-Jan-2022 Proposed issue of securities - RHY
6-Jan-2022 Rhythm Expands CE Mark Registration for ColoSTAT
6-Jan-2022 Rhythm Expands CE Mark Registration for ColoSTAT
2021 Announcements
17-Dec-2021 Cleansing Notice
17-Dec-2021 Cleansing Notice
2021-12-17 Application for quotation of securities RHY
2021-12-17 Application for quotation of securities RHY
2021-12-15 Initial Directors Interest Notice
2021-12-15 Initial Directors Interest Notice
2021-12-14 RHY Platform Technology Targets Five Cancers
2021-12-14 RHY Platform Technology Targets Five Cancers
2021-12-13 Cleansing Notice
2021-12-13 Cleansing Notice
2021-12-13 Application for quotation of securities RHY
2021-12-13 Application for quotation of securities RHY
13-Dec-2021 Appointment of New Non-Executive Director
13-Dec-2021 Appointment of New Non-Executive Director
2-Dec-2021 Cleansing Notice
2-Dec-2021 Cleansing Notice
2-Dec-2021 Application for quotation of securities - RHY
2-Dec-2021 Application for quotation of securities - RHY
1-Dec-2021 Initial Director's Interest Notice
1-Dec-2021 Initial Director's Interest Notice
1-Dec-2021 Board and Management Restructure
1-Dec-2021 Board and Management Restructure
30-Nov-2021 CE Mark Granted for ColoSTAT
30-Nov-2021 CE Mark Granted for ColoSTAT
25-Nov-2021 Change of Director's Interest Notice x 4
25-Nov-2021 Change of Director's Interest Notice x 4
25-Nov-2021 Notification regarding unquoted securities - RHY
25-Nov-2021 Notification regarding unquoted securities - RHY
24-Nov-2021 Results of AGM
24-Nov-2021 Results of AGM
24-Nov-2021 Results of Meeting
24-Nov-2021 Results of Meeting
24-Nov-2021 AGM Presentation
24-Nov-2021 AGM Presentation
12-Nov-2021 Cleansing Notice
12-Nov-2021 Cleansing Notice
12-Nov-2021 Application for quotation of securities - RHY
12-Nov-2021 Application for quotation of securities - RHY
10-Nov-2021 RHY - Institutional Investor Presentation
10-Nov-2021 RHY - Institutional Investor Presentation
29-Oct-2021 Appendix 4C - quarterly
29-Oct-2021 Appendix 4C - quarterly
26-Oct-2021 Ceasing to be a substantial holder
26-Oct-2021 Ceasing to be a substantial holder
25-Oct-2021 Rhythm Biosciences - Investor Presentation
25-Oct-2021 Rhythm Biosciences - Investor Presentation
22-Oct-2021 Proposed issue of securities - RHY
22-Oct-2021 Proposed issue of securities - RHY
21-Oct-2021 ColoSTAT Test Kits Deliver Consistent, High Accuracy Results
21-Oct-2021 ColoSTAT Test Kits Deliver Consistent, High Accuracy Results
20-Oct-2021 Notice of Annual General Meeting Proxy Form
20-Oct-2021 Notice of Annual General Meeting Proxy Form
5-Oct-2021 Rhythm Receives $2.4m R&D Tax Incentive
5-Oct-2021 Rhythm Receives $2.4m R&D Tax Incentive
4-Oct-2021 Notice Required Under ASX Listing Rule 3.13.1
4-Oct-2021 Notice Required Under ASX Listing Rule 3.13.1
29-Sep-2021 Change in substantial holding
29-Sep-2021 Change in substantial holding
22-Sep-2021 Rhythm Completes Recruitment for Clinical Trial (Study 7)
22-Sep-2021 Rhythm Completes Recruitment for Clinical Trial (Study 7)
14-Sep-2021 TGA Accepts Initial Regulatory Documentation
14-Sep-2021 TGA Accepts Initial Regulatory Documentation
13-Sep-2021 Cleansing Notice
13-Sep-2021 Cleansing Notice
13-Sep-2021 Notification regarding unquoted securities - RHY
13-Sep-2021 Notification regarding unquoted securities - RHY
13-Sep-2021 Application for quotation of securities - RHY
13-Sep-2021 Application for quotation of securities - RHY
9-Sep-2021 Change of Director's Interest Notice x 4
9-Sep-2021 Change of Director's Interest Notice x 4
9-Sep-2021 Notification regarding unquoted securities - RHY
9-Sep-2021 Notification regarding unquoted securities - RHY
9-Sep-2021 Application for quotation of securities - RHY
9-Sep-2021 Application for quotation of securities - RHY
7-Sep-2021 Proposed issue of securities - RHY
7-Sep-2021 Proposed issue of securities - RHY
7-Sep-2021 Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
7-Sep-2021 Rhythm Completes Strongly Oversubscribed $4.3M Rights Issue
31-Aug-2021 Appendix 4G and Corporate Governance Statement
31-Aug-2021 Appendix 4G and Corporate Governance Statement
31-Aug-2021 Annual Report
31-Aug-2021 Annual Report
31-Aug-2021 Appendix 4E
31-Aug-2021 Appendix 4E
31-Aug-2021 No Extension to Rights Issue Offer Closing Date
31-Aug-2021 No Extension to Rights Issue Offer Closing Date
19-Aug-2021 Initial TGA Regulatory Documentation Submitted
19-Aug-2021 Initial TGA Regulatory Documentation Submitted
10-Aug-2021 Letter to ineligible shareholders
10-Aug-2021 Letter to ineligible shareholders
10-Aug-2021 Non Renounceable pro rata offer - Completion of despatch
10-Aug-2021 Non Renounceable pro rata offer - Completion of despatch
4-Aug-2021 Cleansing Notice
4-Aug-2021 Cleansing Notice
4-Aug-2021 Application for quotation of securities - RHY
4-Aug-2021 Application for quotation of securities - RHY
30-Jul-2021 Securities Trading Policy
30-Jul-2021 Securities Trading Policy
30-Jul-2021 Update - Proposed issue of securities - RHY
30-Jul-2021 Update - Proposed issue of securities - RHY
30-Jul-2021 Rights Issue Investor Presentation
30-Jul-2021 Rights Issue Investor Presentation
30-Jul-2021 Appendix 4C - quarterly
30-Jul-2021 Appendix 4C - quarterly
30-Jul-2021 Proposed issue of securities - RHY
30-Jul-2021 Proposed issue of securities - RHY
30-Jul-2021 Non renouneable rights issue prospectus
30-Jul-2021 Non renouneable rights issue prospectus
30-Jul-2021 Rights issue to raise approximately $4.3 million
30-Jul-2021 Rights issue to raise approximately $4.3 million
28-Jul-2021 Trading Halt
28-Jul-2021 Trading Halt
27-Jul-2021 Proposed issue of securities - RHY
27-Jul-2021 Proposed issue of securities - RHY
26-Jul-2021 Notification regarding unquoted securities - RHY
26-Jul-2021 Notification regarding unquoted securities - RHY
15-Jul-2021 Rhythm Establishes US Entity To Drive US Expansion Strategy
15-Jul-2021 Rhythm Establishes US Entity To Drive US Expansion Strategy
15-Jul-2021 Final Director's Interest Notice
15-Jul-2021 Final Director's Interest Notice
17-Jun-2021 Rhythm to Present at MST Access Investor Conference
17-Jun-2021 Rhythm to Present at MST Access Investor Conference
16-Jun-2021 RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
16-Jun-2021 RHY adds Sonic Clinical Services to ColoSTAT Clinical Trial
18-May-2021 FY22 Strategic Update
18-May-2021 FY22 Strategic Update
6-May-2021 Rhythm Betters ColoSTAT Results
6-May-2021 Rhythm Betters ColoSTAT Results
27-Apr-2021 Appendix 4C - quarterly
27-Apr-2021 Appendix 4C - quarterly
20-Apr-2021 Appendix 2A and Cleansing Notice
20-Apr-2021 Appendix 2A and Cleansing Notice
13-Apr-2021 Rhythm Extends ColoSTAT Clinical Trial to Western Australia
13-Apr-2021 Rhythm Extends ColoSTAT Clinical Trial to Western Australia
31-Mar-2021 Rhythm Retains ISO13485 Certification
31-Mar-2021 Rhythm Retains ISO13485 Certification
16-Mar-2021 Study 6 Successfully Concluded - Exceptional Results
16-Mar-2021 Study 6 Successfully Concluded - Exceptional Results
25-Feb-2021 Appendix 4D and Half Yearly Report and Accounts
25-Feb-2021 Appendix 4D and Half Yearly Report and Accounts
11-Feb-2021 Rhythm Expands ColoSTAT Clinical Trial To Tenth Site
11-Feb-2021 Rhythm Expands ColoSTAT Clinical Trial To Tenth Site
5-Feb-2021 Appendix 2A and Cleansing Notice
5-Feb-2021 Appendix 2A and Cleansing Notice
29-Jan-2021 Rhythm Top 20 Shareholder Update
29-Jan-2021 Rhythm Top 20 Shareholder Update
28-Jan-2021 Appendix 4C - quarterly
28-Jan-2021 Appendix 4C - quarterly
20-Jan-2021 Initial Manufacturing of ColoSTAT Test-Kits Complete
20-Jan-2021 Initial Manufacturing of ColoSTAT Test-Kits Complete
19-Jan-2021 Rhythm Advances ColoSTAT Study 7
19-Jan-2021 Rhythm Advances ColoSTAT Study 7
11-Jan-2021 Change in substantial holding
11-Jan-2021 Change in substantial holding
ResponsetoASXPriceQuery
ResponsetoASXPriceQuery
2020 Announcements
21-Dec-2020 Investor Presentation - December 2020
21-Dec-2020 Investor Presentation - December 2020
17-Dec-2020 Rhythm Secures US Patent - Strengthens Global Footprint
17-Dec-2020 Rhythm Secures US Patent - Strengthens Global Footprint
2-Dec-2020 Rhythm Appoints Global Manufacturer for ColoSTAT
2-Dec-2020 Rhythm Appoints Global Manufacturer for ColoSTAT
20-Nov-2020 Change of Director's Interest Notice
20-Nov-2020 Change of Director's Interest Notice
19-Nov-2020 Investor Presentation
19-Nov-2020 Investor Presentation
18-Nov-2020 Amended Constitution
18-Nov-2020 Amended Constitution
18-Nov-2020 Results of Meeting
18-Nov-2020 Results of Meeting
18-Nov-2020 AGM Presentation - November 2020
18-Nov-2020 AGM Presentation - November 2020
12-Nov-2020 ColoSTAT Prototype Complete, Outperforms FIT
12-Nov-2020 ColoSTAT Prototype Complete, Outperforms FIT
29-Oct-2020 Appendix 4C - quarterly
29-Oct-2020 Appendix 4C - quarterly
27-Oct-2020 Ethics Approval Received, New Clinical Trial Site Added
27-Oct-2020 Ethics Approval Received, New Clinical Trial Site Added
16-Oct-2020 Rhythm Receives $1.1m R&D Tax Incentive
16-Oct-2020 Rhythm Receives $1.1m R&D Tax Incentive
6-Oct-2020 Notice of Annual General Meeting
6-Oct-2020 Notice of Annual General Meeting
6-Oct-2020 2020 AGM - Letter to Shareholders & Proxy Form
6-Oct-2020 2020 AGM - Letter to Shareholders & Proxy Form
29-Sep-2020 Final Two Adjunct Biomarkers Technically Validated
29-Sep-2020 Final Two Adjunct Biomarkers Technically Validated
23-Sep-2020 New Clinical Trial Site Contracted and Recruiting
23-Sep-2020 New Clinical Trial Site Contracted and Recruiting
16-Sep-2020 Notice Required Under ASX Listing Rule 3.13.1
16-Sep-2020 Notice Required Under ASX Listing Rule 3.13.1
16-Sep-2020 Rhythm Successfully Validates Two Adjunct Biomarkers
16-Sep-2020 Rhythm Successfully Validates Two Adjunct Biomarkers
31-Aug-2020 Appendix 4E
31-Aug-2020 Appendix 4E
28-Aug-2020 Close of Non-Renounceable Rights Issue
28-Aug-2020 Close of Non-Renounceable Rights Issue
25-Aug-2020 Results of Meeting
25-Aug-2020 Results of Meeting
31-Jul-2020 Letter to ineligible shareholders
31-Jul-2020 Letter to ineligible shareholders
31-Jul-2020 Non-renounceable rights issue Offer
31-Jul-2020 Non-renounceable rights issue Offer
31-Jul-2020 Non Renounceable pro rata offer-Completion of despatch
31-Jul-2020 Non Renounceable pro rata offer-Completion of despatch
9-Sep-2020 Cancellation of Options & Current LTI Plan
9-Sep-2020 Cancellation of Options & Current LTI Plan
9-Sep-2020 Notice of change of interests of substantial holder
9-Sep-2020 Notice of change of interests of substantial holder
4-Sep-2020 Notice of Initial Substantial Holder - amended
4-Sep-2020 Notice of Initial Substantial Holder - amended
3-Sep-2020 Notice of initial substantial holder
3-Sep-2020 Notice of initial substantial holder
3-Sep-2020 Change of Director's Interest Notice x 4
3-Sep-2020 Change of Director's Interest Notice x 4
3-Sep-2020 Appendix 2A and Cleansing Notice
3-Sep-2020 Appendix 2A and Cleansing Notice
1-Sep-2020 Entitlement Offer - Results
1-Sep-2020 Entitlement Offer - Results
31-Aug-2020 Appendix 4G and Corporate Governance Statement
31-Aug-2020 Appendix 4G and Corporate Governance Statement
31-Aug-2020 Annual Report
31-Aug-2020 Annual Report
31-Aug-2020 Appendix 4E
31-Aug-2020 Appendix 4E
28-Aug-2020 Close of Non-Renounceable Rights Issue
28-Aug-2020 Close of Non-Renounceable Rights Issue
25-Aug-2020 Results of Meeting
25-Aug-2020 Results of Meeting
31-Jul-2020 Letter to ineligible shareholders
31-Jul-2020 Letter to ineligible shareholders
31-Jul-2020 Non-renounceable rights issue Offer
31-Jul-2020 Non-renounceable rights issue Offer
31-Jul-2020 Non Renounceable pro rata offer-Completion of despatch
31-Jul-2020 Non Renounceable pro rata offer-Completion of despatch
29-Jul-2020 Appendix 2A and Cleansing Notice
29-Jul-2020 Appendix 2A and Cleansing Notice
29-Jul-2020 Appendix 4C - quarterly
29-Jul-2020 Appendix 4C - quarterly
23-Jul-2020 Notice of General Meeting-Proxy Form
23-Jul-2020 Notice of General Meeting-Proxy Form
23-Jul-2020 Cleansing Notice
23-Jul-2020 Cleansing Notice
23-Jul-2020 Proposed issue of Securities - RHY
23-Jul-2020 Proposed issue of Securities - RHY
23-Jul-2020 Placement & Rights Offer to raise approximately $6 million
23-Jul-2020 Placement & Rights Offer to raise approximately $6 million
17-Jul-2020 Trading Halt
17-Jul-2020 Trading Halt
10-Jun-2020 Change of Company Address
10-Jun-2020 Change of Company Address
5-Jun-2020 Appointment of Non-Executive Director & Appendix 3X
5-Jun-2020 Appointment of Non-Executive Director & Appendix 3X
23-Apr-2020 Appendix 4C - quarterly
23-Apr-2020 Appendix 4C - quarterly
9-Apr-2020 COVID-19 Update
9-Apr-2020 COVID-19 Update
6-Apr-2020 Successful ISO13485 Surveillance Audit
6-Apr-2020 Successful ISO13485 Surveillance Audit
2-Apr-2020 Rhythm Successfully Validates Key Biomarker
2-Apr-2020 Rhythm Successfully Validates Key Biomarker
26-Feb-2020 Appendix 4D and Half Yearly Report and Accounts
26-Feb-2020 Appendix 4D and Half Yearly Report and Accounts
30-Jan-2020 Appendix 4C - quarterly
30-Jan-2020 Appendix 4C - quarterly
29-Jan-2020 Change of Auditor
29-Jan-2020 Change of Auditor
6-Jan-2020 Lapse of performance rights - Appendix 3B
6-Jan-2020 Lapse of performance rights - Appendix 3B
2019 Announcements
10-Dec-2019 Appendix 3B - release of escrow securities
10-Dec-2019 Appendix 3B - release of escrow securities
2-Dec-2019 Ceasing to be a substantial holder
2-Dec-2019 Ceasing to be a substantial holder
15-Nov-2019 Release from ASX Escrow
15-Nov-2019 Release from ASX Escrow
4-Nov-2019 Rhythm Biosciences Granted China Patent
4-Nov-2019 Rhythm Biosciences Granted China Patent
29-Oct-2019 Appendix 4C - quarterly
29-Oct-2019 Appendix 4C - quarterly
28-Oct-2019 Appointment of Chairman & Appendix 3X
28-Oct-2019 Appointment of Chairman & Appendix 3X
28-Oct-2019 Results of Meeting
28-Oct-2019 Results of Meeting
28-Oct-2019 AGM Presentation October 2019
28-Oct-2019 AGM Presentation October 2019
25-Oct-2019 Final Director's Interest Notice
25-Oct-2019 Final Director's Interest Notice
25-Oct-2019 Resignation of Director - New Chairman Secured
25-Oct-2019 Resignation of Director - New Chairman Secured
18-Oct-2019 Change in substantial holding
18-Oct-2019 Change in substantial holding
23-Sep-2019 Change in substantial holding
23-Sep-2019 Change in substantial holding
19-Sep-2019 ColoSTAT - Test Development Update
19-Sep-2019 ColoSTAT - Test Development Update
17-Sep-2019 Notice of Annual General Meeting-Proxy Form
17-Sep-2019 Notice of Annual General Meeting-Proxy Form
29-Aug-2019 Appendix 4G and Corporate Governance Statement
29-Aug-2019 Appendix 4G and Corporate Governance Statement
29-Aug-2019 Annual Report
29-Aug-2019 Annual Report
29-Aug-2019 Appendix 4E
29-Aug-2019 Appendix 4E
25-Jul-2019 Corporate Presentation - July 2019
25-Jul-2019 Corporate Presentation - July 2019
25-Jul-2019 Appendix 4C
25-Jul-2019 Appendix 4C
26-Jun-2019 Rhythm signs Alfred Hospital for ColoSTAT clinical trial
26-Jun-2019 Rhythm signs Alfred Hospital for ColoSTAT clinical trial
18-Jun-2019 Monash Health signed with first patients recruited
18-Jun-2019 Monash Health signed with first patients recruited
22-May-2019 Rhythm Biosciences receives ISO certification
22-May-2019 Rhythm Biosciences receives ISO certification
30-Apr-2019 Appendix 4C - quarterly
30-Apr-2019 Appendix 4C - quarterly
18-Mar-2019 Rhythm recruits first patient in ColoSTAT clinical trial
18-Mar-2019 Rhythm recruits first patient in ColoSTAT clinical trial
26-Feb-2019 Appendix 4D and Half Yearly Report and Accounts
26-Feb-2019 Appendix 4D and Half Yearly Report and Accounts
20-Feb-2019 RHY Signs first ColoSTAT site for Clinical Trial - Study 7
20-Feb-2019 RHY Signs first ColoSTAT site for Clinical Trial - Study 7
11-Feb-2019 Corporate Presentation
11-Feb-2019 Corporate Presentation
8-Feb-2019 Rhythm secures ethics approval for ColoSTAT clinical trial
8-Feb-2019 Rhythm secures ethics approval for ColoSTAT clinical trial
29-Jan-2019 Appendix 4C
29-Jan-2019 Appendix 4C
23-Jan-2019 RHY Welcomes Australian Government's $10m Investment
23-Jan-2019 RHY Welcomes Australian Government's $10m Investment
2018 Announcements
11-Dec-2018 Rhythm Receives R&D Tax Incentive Refund
11-Dec-2018 Rhythm Receives R&D Tax Incentive Refund
5-Dec-2018 Rhythm Completes Reagent Development Program
5-Dec-2018 Rhythm Completes Reagent Development Program
28-Nov-2018 Appointment of CEO - Senior Management Changes
28-Nov-2018 Appointment of CEO - Senior Management Changes
26-Nov-2018 Results of Meeting
26-Nov-2018 Results of Meeting
26-Nov-2018 AGM Presentation
26-Nov-2018 AGM Presentation
14-Nov-2018 Change of Director's Interest Notice
14-Nov-2018 Change of Director's Interest Notice
29-Oct-2018 Appendix 4C
29-Oct-2018 Appendix 4C
12-Oct-2018 Notice of Annual General Meeting-Proxy Form
12-Oct-2018 Notice of Annual General Meeting-Proxy Form
3-Oct-2018 Final Antibody Selection Complete
3-Oct-2018 Final Antibody Selection Complete
31-Aug-2018 Appendix 4G and Corporate Governance Statement
31-Aug-2018 Appendix 4G and Corporate Governance Statement
31-Aug-2018 Annual Report
31-Aug-2018 Annual Report
31-Aug-2018 Appendix 4E
31-Aug-2018 Appendix 4E
29-Aug-2018 Appendix 3B - release from escrow
29-Aug-2018 Appendix 3B - release from escrow
13-Aug-2018 Change in substantial holding
13-Aug-2018 Change in substantial holding
6-Aug-2018 Release of Restricted Securities from Escrow
6-Aug-2018 Release of Restricted Securities from Escrow
30-Jul-2018 Appendix 4C
30-Jul-2018 Appendix 4C
21-Jun-2018 Rhythm completes cloning of key reagent ahead of schedule
21-Jun-2018 Rhythm completes cloning of key reagent ahead of schedule
15-Jun-2018 Merchant Group increases stake in Rhythm from 5% to 7%
15-Jun-2018 Merchant Group increases stake in Rhythm from 5% to 7%
12-Jun-2018 RHY Welcomes Leading Biotech Fund as New Major Shareholder
12-Jun-2018 RHY Welcomes Leading Biotech Fund as New Major Shareholder
22-May-2018 Appendix 3B
22-May-2018 Appendix 3B
22-May-2018 Key Management Appointments at Rhythm Biosciences
22-May-2018 Key Management Appointments at Rhythm Biosciences
16-May-2018 Rhythm Granted Biomarker Patent in Europe
16-May-2018 Rhythm Granted Biomarker Patent in Europe
14-May-2018 RHY's Four Antibodies Pass all Three Key Screening Tests
14-May-2018 RHY's Four Antibodies Pass all Three Key Screening Tests
30-Apr-2018 Appendix 4C
30-Apr-2018 Appendix 4C
24-Apr-2018 Reagent Development Update
24-Apr-2018 Reagent Development Update
23-Mar-2018 Change of Director's Interest Notice
23-Mar-2018 Change of Director's Interest Notice
1-Mar-2018 Appendix 4D - Half Yearly Report
1-Mar-2018 Appendix 4D - Half Yearly Report
27-Feb-2018 Half Yearly Report and Accounts
27-Feb-2018 Half Yearly Report and Accounts
15-Feb-2018 Consultation with Major Diagnostic Labs Underway - Update
15-Feb-2018 Consultation with Major Diagnostic Labs Underway - Update
7-Feb-2018 Rhythm reports reagent development update
7-Feb-2018 Rhythm reports reagent development update
31-Jan-2018 Quarterly report and Appendix 4C
31-Jan-2018 Quarterly report and Appendix 4C
24-Jan-2018 CSIRO and Rhythm Commence Development of Key Reagents
24-Jan-2018 CSIRO and Rhythm Commence Development of Key Reagents
9-Jan-2018 CSIRO to assist Rhythm Biosciences develop key reagents
9-Jan-2018 CSIRO to assist Rhythm Biosciences develop key reagents
2017 Announcements
7-Dec-2017 Becoming a substantial holder
7-Dec-2017 Becoming a substantial holder
6-Dec-2017 Appendix 3X - Lockett
6-Dec-2017 Appendix 3X - Lockett
6-Dec-2017 Appendix 3X - Tanner
6-Dec-2017 Appendix 3X - Tanner
6-Dec-2017 Appendix 3X - Panaccio
6-Dec-2017 Appendix 3X - Panaccio
6-Dec-2017 Appendix 3X - White
6-Dec-2017 Appendix 3X - White
6-Dec-2017 Corporate Governance Statement
6-Dec-2017 Corporate Governance Statement
6-Dec-2017 Audited Special Purpose Report 1-6-17 to 30-6-17
6-Dec-2017 Audited Special Purpose Report 1-6-17 to 30-6-17
6-Dec-2017 Audited Special Purpose Report 1-7-17 to 31-8-17
6-Dec-2017 Audited Special Purpose Report 1-7-17 to 31-8-17
6-Dec-2017 Securities Trading Policy
6-Dec-2017 Securities Trading Policy
6-Dec-2017 Performance Rights Plan
6-Dec-2017 Performance Rights Plan
6-Dec-2017 Employee Security Ownership Plan
6-Dec-2017 Employee Security Ownership Plan
6-Dec-2017 Constitution
6-Dec-2017 Constitution
6-Dec-2017 Top 20 Shareholders
6-Dec-2017 Top 20 Shareholders
6-Dec-2017 Distribution Schedule
6-Dec-2017 Distribution Schedule
6-Dec-2017 Pre-quotation Disclosure
6-Dec-2017 Pre-quotation Disclosure
6-Dec-2017 Appendix 1A and Information Form and Checklist
6-Dec-2017 Appendix 1A and Information Form and Checklist
6-Dec-2017 Replacement Prospectus
6-Dec-2017 Replacement Prospectus
6-Dec-2017 Admission to Official List
6-Dec-2017 Admission to Official List
6-Dec-2017 ASX Notice - Admission and Quotation
6-Dec-2017 ASX Notice - Admission and Quotation

About us:

RHYTHM BIOSCIENCES

Contact

Rhythm Biosciences

Bio21 Institute
30 Flemington Road
Parkville VIC 3010
Australia

Keep up to date:

Connect with us:

JOIN OUR
MAILING LIST